Quantum dot 705, a cadmium-based nanoparticle, induces persistent inflammation and granuloma formation in the mouse lung

Nanotoxicology

Volumn 7, Issue 1, 2013, Pages 105-115

  Ho, Chia Chi ^a,b   Chang, Han ^c,d   Tsai, Hui Ti ^b   Tsai, Ming Hsien ^b   Yang, Chung Shi ^b   Ling, Yong Chien ^a   Lin, Pinpin ^b  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Biomaterials; Lung granuloma; Nanotoxicology; Quantum dots

Indexed keywords

CXCL1 CHEMOKINE; CXCL13 CHEMOKINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROGOL; MACROPHAGE ELASTASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; QUANTUM DOT; QUANTUM DOT 705; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE EXPRESSION; INFLAMMATION; LUNG FUNCTION; LUNG GRANULOMA; LUNG LAVAGE; LUNG PARENCHYMA; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH2 CELL; VITAL CAPACITY;

ANIMALS; CADMIUM; CELL LINE; GRANULOMA; MICE; MICE, INBRED ICR; NANOPARTICLES; PNEUMONIA; QUANTUM DOTS;

EID: 84872163391     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2011.635814     Document Type: Article

References (48)

1. Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. 2004. Noninvasive imaging of quantum dots in mice. Bioconjug Chem 15:79-86. (Pubitemid 38165983)
2. Chan WH, Shiao NH, Lu PZ. 2006. CdSe quantum dots induce apoptosis in human neuroblastoma cells via mitochondrial-dependent pathways and inhibition of survival signals. Toxicol Lett 167:191-200.
3. Chang E, Thekkek N, Yu WW, Colvin VL, Drezek R. 2006. Evaluation of quantum dot cytotoxicity based on intracellular uptake. Small 2:1412-1417. (Pubitemid 44786881)
4. Chen AA, Derfus AM, Khetani SR, Bhatia SN. 2005. Quantum dots to monitor RNAi delivery and improve gene silencing. Nucleic Acids Res 33:e190. (Pubitemid 43125090)
5. Chen ES, Moller DR. 2007. Expression profiling in granulomatous lung disease. Proc Am Thorac Soc 4:101-107. (Pubitemid 46067568)
6. Dabbousi BO, Rodriguez-Viejo J, Mikulec FV, Heine JR, Mattoussi H, Ober R, et al. 1997. (CdSe)ZnS core-shell quantum dots: Synthesis and characterization of a size series of highly luminescent nanocrystallites. J Phys Chem 101:9463-9475. (Pubitemid 127581259)
7. Denis M, Bedard M, Laviolette M, Cormier Y. 1993. A study of monokine release and natural killer activity in the bronchoalveolar lavage of subjects with farmer's lung. Am Rev Respir Dis 147:934-939. (Pubitemid 23093819)
8. Deng Z, Schulz O, Lin S, Ding B, Liu X, Wei X, et al. 2010. Aqueous synthesis of zinc blende CdTe/CdS magic-core/thick-shell tetrahedral- shaped nanocrystals with emission tunable to near-infrared. J Am Chem Soc 132:5592-5593.
9. Erdely A, Hulderman T, Salmen R, Liston A, Zeidler-Erdely PC, Schwegler-Berry D, et al. 2009. Cross-talk between lung and systemic circulation during carbon nanotube respiratory exposure. Potential biomarkers. Nano Lett 9:36-43.
10. Ferrara A2011. Chronic obstructive pulmonary disease. Radiol Technol 82:245-263.
11. Fujimori Y, Kataoka M, Tada S, Takehara H, Matsuo K, Miyake T, et al. 2003. The role of interleukin-8 in interstitial pneumonia. Respirology 8:33-40. (Pubitemid 36504278)
12. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. 2004. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 22:969-976. (Pubitemid 39014473)
13. Gao X, Dave SR. 2007. Quantum dots for cancer molecular imaging. Adv Exp Med Biol 620:57-73.
14. Gao X, Wang T, Wu B, Chen J, Yue Y, Dai N, et al. 2008. Quantum dots for tracking cellular transport of lectin-functionalized nanoparticles. Biochem Biophys Res Commun 377:35-40.
15. Gaspar MM, Gobbo O, Ehrhardt C. 2010. Generation of liposome aerosols with the Aeroneb Pro and the AeroProbe nebulizers. J Liposome Res 20:55-61.
16. Girard M, Israel-Assayag E, Cormier Y. 2004. Pathogenesis of hypersensitivity pneumonitis. Curr Opin Allergy Clin Immunol 4:93-98. (Pubitemid 38581536)
17. Gudmundsson G, Bosch A, Davidson BL, Berg DJ, Hunninghake GW. 1998. Interleukin-10 modulates the severity of hypersensitivity pneumonitis in mice. Am J Respir Cell Mol Biol 19:812-818. (Pubitemid 128353681)
18. Hasegawa M, Sato S, Takehara K. 1999. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis. Clin Exp Immunol 117:159-165. (Pubitemid 29292792)
19. Hauck TS, Anderson RE, Fischer HC, Newbigging S, Chan WC. 2010. In vivo quantum-dot toxicity assessment. Small 6:138-144.
20. Henry CJ, Ornelles DA, Mitchell LM, Brzoza-Lewis KL, Hiltbold EM. 2008. IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17. J Immunol 181:8576-8584.
21. Jia N, Lian Q, Shen H, Wang C, Li X, Yang Z. 2007. Intracellular delivery of quantum dots tagged antisense oligodeoxynucleotides by functionalized multiwalled carbon nanotubes. Nano Lett 7:2976-2980. (Pubitemid 350132915)
22. Karathanasis E, Ayyagari AL, Bhavane R, Bellamkonda RV, Annapragada AV. 2005. Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery. J Control Release 103:159-175. (Pubitemid 40248570)
23. Kaufmann SH, Ladel CH. 1994. Role of T cell subsets in immunity against intracellular bacteria: experimental infections of knock-out mice with Listeria monocytogenes and Mycobacterium bovis BCG. Immunobiology 191:509-519. (Pubitemid 24331477)
24. Lam CW, James JT, McCluskey R, Hunter RL. 2004. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 77:126-134. (Pubitemid 38128652)
25. Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M, Moser B. 1998. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 187:655-660. (Pubitemid 28093368)
26. Lin CH, Yang MH, Chang LW, Yang CS, Chang H, Chang WH, et al. 2011. Cd/Se/Te-based quantum dot 705 modulated redox homeostasis with hepatotoxicity in mice. Nanotoxicology. Posted online on December 10, 2010. (doi:10.3109/17435390.2010.539712)
27. Lin P, Chen JW, Chang LW, Wu JP, Redding L, Chang H, et al. 2008. Computational and ultrastructural toxicology of a nanoparticle, Quantum Dot 705, in mice. Environ Sci Technol 42:6264-6270.
28. Liu J, Gong T, Fu H, Wang C, Wang X, Chen Q, et al. 2008. Solid lipid nanoparticles for pulmonary delivery of insulin. Int J Pharm 356:333-344.
29. Lovric J, Cho SJ, Winnik FM, Maysinger D. 2005. Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chem Biol 12:1227-1234. (Pubitemid 41628258)
30. Mahto SK, Park C, Yoon TH, Rhee SW. 2010. Assessment of cytocompatibility of surface-modified CdSe/ZnSe quantum dots for BALB/ 3T3 fibroblast cells. Toxicol In Vitro 24:1070-1077.
31. Manabe N, Hoshino A, Liang YQ, Goto T, Kato N, Yamamoto K2006. Quantum dot as a drug tracer in vivo. IEEE Trans Nanobioscience 5:263-267. (Pubitemid 44955826)
32. Mansour HM, Rhee YS, Wu X. 2009. Nanomedicine in pulmonary delivery. Int J Nanomedicine 4:299-319.
33. Meldrum DR, Meng X, Sheridan BC, McIntyre RC Jr, Harken AH, Banerjee A. 1998. Tissue-specific protein kinase C isoforms differentially mediate macrophage TNFalpha and IL-1beta production. Shock 9:256-260. (Pubitemid 128463293)
34. Monteiro-Riviere NA, Inman AO, Zhang LW. 2009. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol 234: 222-235.
35. Mulder WJ, Strijkers GJ, Nicolay K, Griffioen AW. 2010. Quantum dots for multimodal molecular imaging of angiogenesis. Angiogenesis 13:131-134.
36. Nakayama T, Hieshima K, Nagakubo D, Sato E, Nakayama M, Kawa K, et al. 2004. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J Virol 78:1665-1674. (Pubitemid 38176699)
37. Nathan N, Denizot Y. 1998. Anti-inflammatory cytokines (IL-4, IL-10, IL-13) in plasma during mesenteric infarction. Mediators Inflamm 7:119. (Pubitemid 28238125)
38. Nenan S, Boichot E, Lagente V, Bertrand CP. 2005. Macrophage elastase (MMP-12): a pro-inflammatory mediator? Mem Inst Oswaldo Cruz 100(Suppl 1):167-172. (Pubitemid 40685458)
39. Obonyo O, Fisher E, Edwards M, Douroumis D. 2010. Quantum dots synthesis and biological applications as imaging and drug delivery systems. Crit Rev Biotechnol 30:283-301.
40. Park EJ, Yoon J, Choi K, Yi J, Park K. 2009. Induction of chronic inflammation in mice treated with titanium dioxide nanoparticles by intratracheal instillation. Toxicology 260:37-46.
41. Pejnovic N, Tomic O, Vojvodic D, Djordjevic N, Jovicic Z, Kukic Z, et al. 1994. IL-1, TNF and IL-6 production by alveolar mononuclear cells in patients with sarcoidosis. Srp Arh Celok Lek 122(Suppl 1):96-97.
42. Qi L, Gao X2008. Emerging application of quantum dots for drug delivery and therapy. Expert Opin Drug Deliv 5:263-267. (Pubitemid 351454377)
43. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. 2006. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci 91:159-165.
44. Schuyler M, Gott K, Cherne A. 2000. Mediators of hypersensitivity pneumonitis. J Lab Clin Med 136:29-38.
45. Veronese FM, Pasut G. 2005. PEGylation, successful approach to drug delivery. Drug Discov Today 10:1451-1458. (Pubitemid 41483874)
46. Xing Y, Smith AM, Agrawal A, Ruan G, Nie S. 2006. Molecular profiling of single cancer cells and clinical tissue specimens with semiconductor quantum dots. Int J Nanomedicine 1:473-481.
47. Zhang H, Yee D, Wang C. 2008. Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. Nanomedicine (Lond) 3:83-91. (Pubitemid 351611867)
48. Zhang Y, Zhu J, Tang Y, Chen X, Yang Y. 2009. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery. Drug Dev Ind Pharm 35:1059-1065.